Michael Saad Lowson

The self-represented applicant moved to set aside a final panel decision of the Divisional Court that had dismissed his application to halt pediatric COVID-19 vaccinations.

The applicant alleged that newly discovered evidence showed the Chief Medical Officer of Health had an undisclosed conflict of interest involving Pfizer, which amounted to fraud.

The court dismissed the motion under Rule 2.1 as frivolous, vexatious, and an abuse of process, finding that the fresh evidence would not affect the core findings that the applicant lacked standing and failed to plead an arguable claim.

The self-represented applicants sought an extension of time to bring a motion to review an order quashing their application for judicial review regarding COVID-19 vaccinations for children.

The applicants had initially appealed to the Court of Appeal, which quashed the appeal for lack of jurisdiction.

The Divisional Court granted the extension, noting that the applicants had a timely intention to appeal but took the wrong route, and that the justice of the case favoured allowing them to challenge the summary dismissal of their application.